TY  - RPRT
TI  - Combinations of RAS pathway inhibitors with targeted agents are active in spheroids of patient-derived cells with oncogenic KRAS variants from multiple cancer types
AU  - Davoudi, Z.
AU  - Dexheimer, T. S.
AU  - Coussens, N. P.
AU  - Silvers, T.
AU  - Morris, J.
AU  - Takebe, N.
AU  - Doroshow, J. H.
AU  - Teicher, B. A.
PY  - 2024
DO  - 10.1101/2024.11.17.623998
UR  - https://www.biorxiv.org/content/10.1101/2024.11.17.623998v1
ID  - 10.1101/2024.11.17.623998
ER  -